The complex and diverse pharmacological effects of BBR, such as regulation of lipid and glucose metabolism and increased insulin sensitivity, may elucidate its promising role in the treatment of NAFLD [57]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.